Cargando…

Preparation and Characterization of a Murine Monoclonal Antibody (MDR3M) Reactive with mdr3 Gene Product

A murine monoclonal antibody (MDR3M) (isotype: IgM) reactive with mdr3 gene product was generated by immunizing mice with mdr3‐specific peptide (H(2)N‐(12)WRPTSAEGDFELGISSKQKRKKTKTVKMI(41)G‐COOH) and hybridizing the primed mouse splenic B cells with X63‐Ag8,6.5.3 mouse plasmacytoma cells. MDR3M did...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sugawara, Isamu, Hirata, Akio, Ueda, Kazumitsu, Itoyama, Shinji
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 1992
Materias:	Rapid Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5918957/ https://www.ncbi.nlm.nih.gov/pubmed/1328122 http://dx.doi.org/10.1111/j.1349-7006.1992.tb01982.x

Ejemplares similares

Primer‐dependent Amplification of mdr1 mRNA by Polymerase Chain Reaction
por: Sugawara, Isamu, et al.
Publicado: (1992)

Specialized Localization of P‐Glycoprotein Recognized by MRK 16 Monoclonal Antibody in Endothelial Cells of the Brain and the Spinal Cord
por: Sugawara, Isamu, et al.
Publicado: (1990)

Differential recognition of mdr1a and mdr1b gene products in multidrug resistant mouse tumour cell lines by different monoclonal antibodies.
por: Barrand, M. A., et al.
Publicado: (1992)

The siRNA targeted to mdr1b and mdr1a mRNAs in vivo sensitizes murine lymphosarcoma to chemotherapy
por: Patutina, Olga A, et al.
Publicado: (2010)

‘Z(S)-MDR-TB' versus ‘Z(R)-MDR-TB': improving treatment of MDR-TB by identifying pyrazinamide susceptibility
por: Zhang, Ying, et al.
Publicado: (2012)

MDR & XDR Tuberculosis
por: Kumar, Prahlad
Publicado: (2017)

MDR Tuberculosis Treatment
por: Espinosa-Pereiro, Juan, et al.
Publicado: (2022)

A Murine Monoclonal Antibody that Recognizes an Extracellular Domain of the Human c‐erbB‐2 Protooncogene Product
por: Masuko, Takashi, et al.
Publicado: (1989)

Comparison of characteristics and mortality in multidrug resistant (MDR) and non-MDR tuberculosis patients in China
por: Sun, Yanni, et al.
Publicado: (2015)

The effect of varying multidrug-resistence (MDR) definitions on rates of MDR gram-negative rods
por: Wolfensberger, Aline, et al.
Publicado: (2019)

Pluronics and MDR Reversal: An Update
por: Alakhova, Daria Y., et al.
Publicado: (2014)

MDR TB Transmission, Singapore
por: Chee, Cynthia B.E., et al.
Publicado: (2013)

Raltegravir does not revert efflux activity of MDR1-P-glycoprotein in human MDR cells
por: Dupuis, Maria Luisa, et al.
Publicado: (2013)

Convergence of virulence and MDR in a single plasmid vector in MDR Klebsiella pneumoniae ST15
por: Lam, Margaret M C, et al.
Publicado: (2019)

Detection of Multidrug Resistance (MDR1) Gene RNA Expression in Human Tumors by a Sensitive Ribonuclease Protection Assay
por: Ueda, Kazumitsu, et al.
Publicado: (1989)

High MDR‐1 expression by MAIT cells confers resistance to cytotoxic but not immunosuppressive MDR‐1 substrates
por: Fergusson, J.R., et al.
Publicado: (2018)

Patterns, Cost, and Immunological Response of MDR vs. Non MDR-Bacteremia: A Prospective Cohort Study
por: Schinas, Georgios, et al.
Publicado: (2023)

Gestion des Affichages Repetitifs : MDR
por: Merard, L
Publicado: (1984)

MDR1 in immunity: friend or foe?
por: Bossennec, Marion, et al.
Publicado: (2018)

Identification of new interaction partners of the human ABC transporter MDR3
por: Kluth, Marianne, et al.
Publicado: (2014)

A General Framework for Formal Tests of Interaction after Exhaustive Search Methods with Applications to MDR and MDR-PDT
por: Edwards, Todd L., et al.
Publicado: (2010)

Community-based MDR-TB care project improves treatment initiation in patients diagnosed with MDR-TB in Myanmar
por: Wai, Pyae Phyo, et al.
Publicado: (2018)

Identification of genes and pathways associated with MDR in MCF-7/MDR breast cancer cells by RNA-seq analysis
por: Yang, Minlan, et al.
Publicado: (2018)

miR‐495 sensitizes MDR cancer cells to the combination of doxorubicin and taxol by inhibiting MDR1 expression
por: Zou, Zhenyou, et al.
Publicado: (2017)

Efficacy of moxifloxacin & econazole against multidrug resistant (MDR) Mycobacterium tuberculosis in murine model
por: Gupta, U.D., et al.
Publicado: (2015)

MDR1A deficiency restrains tumor growth in murine colitis-associated carcinogenesis
por: Hennenberg, Eva Maria, et al.
Publicado: (2017)

In vitro Anti‐tumor Activity of Anti‐c‐erbB‐2 × Anti‐CD3ɛ Bifunctional Monoclonal Antibody
por: Sugiyama, Yoshihiro, et al.
Publicado: (1992)

Etoposide enhances antitumor efficacy of MDR1-driven oncolytic adenovirus through autoupregulation of the MDR1 promoter activity
por: Su, Bing-Hua, et al.
Publicado: (2015)

Nobiletin and its derivatives overcome multidrug resistance (MDR) in cancer: total synthesis and discovery of potent MDR reversal agents
por: Feng, Senling, et al.
Publicado: (2020)

Characterization of Human Colorectal Cancer MDR1/P-gp Fab Antibody
por: Zhang, Xuemei, et al.
Publicado: (2013)

Mdr3 gene mutation in preterm infants with parenteral nutrition‐associated cholestasis
por: Yang, Xiufang, et al.
Publicado: (2022)

Multidrug resistance (mdr) genes in human cancer.
por: Nooter, K., et al.
Publicado: (1991)

Transmission of MDR and XDR Tuberculosis in Shanghai, China
por: Zhao, Ming, et al.
Publicado: (2009)

Management of MDR-TB: Review of Iran's Experience
por: Masjedi, Mohammad Reza, et al.
Publicado: (2013)

Kinetics of MDR Transport in Tumor-Initiating Cells
por: Koshkin, Vasilij, et al.
Publicado: (2013)

Source of MDR infections in an ICU: busting the myth
por: Agrawal, R
Publicado: (2015)

Phytochemicals: Potential Lead Molecules for MDR Reversal
por: Tinoush, Boshra, et al.
Publicado: (2020)

Fatal MDR Klebsiella in ICU — How was it Dealt with?
por: Khandelwal, Vipul, et al.
Publicado: (2019)

Blood Stream Infections from MDR Bacteria
por: Di Franco, Sveva, et al.
Publicado: (2021)

MDR Pumps as Crossroads of Resistance: Antibiotics and Bacteriophages
por: Nazarov, Pavel A.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_hdflka38bk347gaqu40vp78ig8